Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4. This represents a small metadata update rather than substantive changes to the content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s interface revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor site release rather than any change to the clinical trial information.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded the term 'Gastrointestinal stromal tumor' to the page content. Added a Resources entry linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check74 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.